Plum SEC
  • Korean Market
  • Privacy Policy

Korean Market

  • Reset (View All)

  • ★★★★★
  • ★★★★
  • ★★★
  • ★★
  • ★

  • ★

  • ★
  • ★★
  • ★★★
  • ★★★★
  • ★★★★★
All Disclosures
EXCH
GL Pharm Tech
★

GL Pharm Tech Sets Record Date for Shareholder Opposition Rights in Small-Scale Merger with 100% Subsidiary… No Value Impact

  05/28/2026, 03:13 PM
MATR
GL Pharm Tech
★

GL Pharm Tech Decides to Absorb Wholly-Owned Subsidiary GL Pharma via Small-Scale Merger with No Share Issuance, No Dilution

  05/28/2026, 02:31 PM
EXCH
GL Pharm Tech
★

Record Date Set for Extraordinary General Meeting on June 4

  05/19/2026, 02:14 PM
EXCH
GL Pharm Tech
★

Decision to Convene EGM for 5:1 Reverse Stock Split Approval

  05/19/2026, 02:12 PM
EXCH
GL Pharm Tech
★★

5:1 Reverse Stock Split Decision for Price Stabilization

  05/19/2026, 01:26 PM
PERI
GL Pharm Tech
★★

GL Pharmtech Q1 2026 Revenue Up 20%... Dry Eye Drug GLH8NDE Submitted for Approval

  05/13/2026, 09:36 AM
한국어 | English | 中文 | 日本語
Plum SEC © 2026.05.25
The information provided on this site is for reference only and we do not guarantee its accuracy or completeness. Users are solely responsible for any investment decisions made based on this information.